Weight Gain After Menopause and Midlife Metabolic Changes

After menopause, hormonal shifts and the natural effects of aging can make weight management more challenging and increase cardiometabolic risk. Mayo Clinic researchers note that the drop in estrogen associated with menopause is also linked to changes that may raise cardiovascular risk independent of weight—one reason midlife health strategies often need a more individualized approach. The findings, published in The Lancet Obstetrics, Gynaecology, & Women's Health.

What Researchers Studied: Tirzepatide With and Without Menopausal Hormone Therapy

In a Mayo Clinic–led observational study, investigators reviewed real-world clinical data from 120 postmenopausal women with overweight or obesity who used tirzepatide for weight management for 12 months or longer. They compared outcomes for women taking tirzepatide alone versus women taking tirzepatide while also receiving menopausal hormone therapy, matching groups as closely as possible on key characteristics.

Key Finding: Greater Average Weight Loss in the Combination Group

According to the Mayo Clinic team, women using menopausal hormone therapy alongside tirzepatide lost about 35% more weight than women taking tirzepatide without hormone therapy. The authors emphasize this was not a randomized trial, so the findings do not prove hormone therapy caused the additional weight loss, but they do highlight an important relationship worth further study.

Why the Combination Might Matter for Appetite, Sleep, and Consistency

One explanation, as the Mayo Clinic investigators discuss, is that menopause symptom relief from hormone therapy may improve sleep and quality of life—making it easier to stay consistent with nutrition and physical activity changes. The researchers also cite preclinical data suggesting a potential biological synergy, with estrogen possibly enhancing the appetite-suppressing effects of GLP-1–based medications, which could help explain the observed difference.

What to Know Before Considering Medication Options

Both hormone therapy and GLP-1/GIP-based medications like tirzepatide should be individualized based on symptoms, medical history, labs, risk profile, and goals. The Mayo Clinic authors note that next steps include testing these observations in randomized clinical trials and evaluating whether benefits extend beyond weight loss to cardiometabolic measures.

Get Help With Menopause Symptoms and Midlife Wellness

If menopause-related symptoms are affecting your sleep, mood, energy, or overall wellness, the next step is a personalized plan—not a one-size-fits-all solution. RejuvinAge provides physician -led bioidentical hormone replacement therapy programs for women navigating menopause. Explore our program or reach out with questions to learn whether physician-managed hormone optimization may be appropriate for you.